Skip to main content

Advertisement

SpringerLink
Log in

Plasma Fibronectin Concentration in Obese/Overweight Pregnant Women: A Possible Risk Factor for Preeclampsia

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Plasma fibronectin (FN) levels in obese/overweight and non-obese pregnant women were evaluated as a possible risk factor for preeclampsia. A total of one hundred and sixty three pregnant women attending antenatal clinic at University of Calabar Teaching Hospital participated in the study and sixty non-pregnant women served as control. About 77 (47.24%) of the pregnant women were followed up for any subsequent development of preeclampsia during the pregnancy. Fibronectin levels in plasma were measured by ELISA assay and serum total protein, urea and creatinine were determined spectrophotometrically. The mean plasma FN concentration of non-obese pregnant women in first trimester was lower than those of the non-pregnant women by 24%, but however, increased to the non-pregnant level in second and third trimesters. Obese/overweight pregnant women had significantly (P < 0.05) higher values than non-obese pregnant women in second and third trimesters. FN in obese/overweight pregnant women correlated positively with mean arterial blood pressure (MAP: r = 0.414, P = 0.04). About 28.57% of the pregnant women with FN above cut off point of 330 μg/ml at 18–24 weeks of gestation developed preeclampsia. This value increased to 40.0% when only the obese/overweight women were considered. On analysis of both fibronectin >330 μg/ml and MAP > 90, the predictive value increased to 66.7%. We therefore conclude that elevated FN may be regarded as a risk factor of preeclampsia especially among the obese women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Santas AJ, Peterson JA, Halbleib JL, Craig SE, Humphries MJ, Peters MP. Alternative splicing of the III CS domain in fibronectin governs the role of the heparin II domain in fibrilogenesis and cell spreading. J Biol Chem. 2002;277(16):13650–8.

    Article  PubMed  CAS  Google Scholar 

  2. Mette N, Ozturk IH, Colpan L. Plasma fibronectin and urine glycosaminoglycan levels in rheumatic disease. Trop J Med Sci. 1998;28:437–41.

    Google Scholar 

  3. Kanters SDJ, Banga JD, Algra A, Frijins RCJM, Beutler JJ, Frijnheer R. Plasma levels of cellular fibronectin diabetes. Diabetes Care. 2001;24:323–7.

    Article  PubMed  CAS  Google Scholar 

  4. Man SFP, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Zhang X, Vessey R, Walker TG, Celli BR, Sin DD. Circulation fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J. 2008;32:1451–7.

    Article  PubMed  CAS  Google Scholar 

  5. Song KS, Kim HK, Shim W, Jee SH. Plasma fibronectin levels in ischemic heart disease. Atherosclerosis. 2001;154:449–53.

    Article  PubMed  CAS  Google Scholar 

  6. Waalkes S, Atschekzei F, Kramer MW, Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS, Schrader AJ, Kuczyk MA, Serth J. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer. BMC Cancer. 2010;10:503–9.

    Article  PubMed  Google Scholar 

  7. Warawdeker UM, Zingde SM, Iyer KS, Jgannath P, Mehta AR, Mehta NG. Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointesyinal and head and neck cancer patients. Clin Chim Acta. 2006;372:83–93.

    Article  Google Scholar 

  8. Orem C, Celik S, Orem A, Calapoglu M, Erdol C. Increased plasma fibronectin levels in patients with acute myocardial infarction complicated with left ventricular thrombus. Thromb Res. 2002;105:37–41.

    Article  PubMed  CAS  Google Scholar 

  9. Orem C, Durmus I, Kilinc K, Baykan M, Gokce M, Orem A, Topbas M. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness. Coron Artery Dis. 2003;14(3):219–24.

    PubMed  Google Scholar 

  10. Peters JH, Loredo GA, Chen G, Maunder R, Hahn TI, Wilits NH, Hynes RO. Plasma levels of fibronectin bearing the alternatively spliced EIIIB segment are increased after major trauma. J Lab Clin Med. 2003;141:401–10.

    Article  PubMed  CAS  Google Scholar 

  11. Khong TY, de Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and small for gestational age infants. Brit J Obstet Gynaecol. 1986;93:1049–59.

    Article  CAS  Google Scholar 

  12. Das V, Bhargava T, Das SK, Pandey S. Microablbuminuria: a predictor of pregnancy induced hypertension. Brit J Obstet Gynecol. 1996;103:928–30.

    Article  CAS  Google Scholar 

  13. Cedergren MI. Maternal morbidity, obesity and the risk of adverse pregnant coutcome. Obstet Gynecol. 2004;103:219–26.

    Article  PubMed  Google Scholar 

  14. Jensen DM, Darmm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Ovesen P, Beek-Nielsen H. Pregnancy outcome and prepregnancy body mass index in 2459 glucose tolelrent Danish women. Am J Obstet Gynecol. 2003;189(1):239–44.

    Article  PubMed  Google Scholar 

  15. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S. Maternal obesity and pregnancy outcome. A study of 287213 pregnancy in London. Int J Obstet Rel Metab Disorders. 2001;25(8):1175–82.

    Article  CAS  Google Scholar 

  16. O’Brien TE, Ray JG, Cham WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14:368.

    PubMed  Google Scholar 

  17. Davi G, Guagnano MT, Ciabattoni G, Basilli S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C. Platelet activation in obese women: role of inflammation and oxidative stress. JAMA. 2002;288(16):2008–14.

    Article  PubMed  CAS  Google Scholar 

  18. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol. 2001;98(5):757–62.

    Article  PubMed  CAS  Google Scholar 

  19. Ramsay JE, Ferrel WR, Crawford L, Wallace AM, Greer IA, Saltar N. Maternal obesity is associated with deregulation of metabolic, vascular and inflammatory pathways. J Clin Endocrinol Metab. 2002;87:4231–7.

    Article  PubMed  CAS  Google Scholar 

  20. Robertson WB, Khong TY, Brosens I, DeWolf F, Sheppard BL, Sonrlar J. The placental bed biopsy: review from three European centres. Am J Obstet Gynaecol. 1986;155:401–6.

    CAS  Google Scholar 

  21. Knottnerus JA, Van Weel C, Muris JWM. Evaluation of diagnostic procedures. BMJ. 2002;324:477–80.

    Article  PubMed  Google Scholar 

  22. Tomoda S, Tamura T, Sudo Y, Ogita S. Effects of obesity on pregnant women maternal hemodynamic changes. Am J Perinatol. 1996;13:73–8.

    Article  PubMed  CAS  Google Scholar 

  23. Strevens H, Kristensen K, Langhoff-Roos J, Wide-Swensson D. Blood pressure patterns through consecutive pregnancies are influenced by body mass index. Am J Obstet Gynaecol. 2002;187:1343–8.

    Article  Google Scholar 

  24. Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gynaecology. 2002;123:882–7.

    Google Scholar 

  25. Kane AB, Kumar V. Environmental and nutritional pathology. In: Kumar V, Abbas AK, Facusto N, editors. Pathologic basis of disease. 7th ed. London: Saunder Company; 2004. p. 415–68.

    Google Scholar 

  26. Ostlund E, Hansson LO, Bremme K. Fribronectin is a marker for organ involvement and may reflect the severity of preeclampsia. Hyperten Pregnancy. 2001;20(1):79–87.

    CAS  Google Scholar 

  27. Chavarria ME, Lava–Gonzalez L, Gonzalez–Gleason A, Sojo I, Reyes A. Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol. 2002;187:595–601.

    Article  PubMed  CAS  Google Scholar 

  28. Panevia-Masin J, Zafironvska K, Bogdanoska S, Lozance L, Gerasimoveska B. Changes in plasma fibronectin levels in pregnancy induced hypertension. Acta Med Croat. 2002;54(45):157–60.

    Google Scholar 

  29. Ascarelli MH, Morrison JE. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv. 1997;1:1–5.

    Article  Google Scholar 

  30. Lopez RL, Francies JA, Garite TJ, Dubyak JM. Fetal fibronectin detection as a predictor of preferm birth in actual clinical practice. Am J Obstet Gynecol. 2000;182(5):1103–6.

    Article  PubMed  CAS  Google Scholar 

  31. Innes KE, Wimsatt JH. Pregnancy-induced hypertension and insulin resistance evidence for connection. Acta Obstet Gynecol Scand. 1999;78:283–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemical Pathology, Faculty of Clinical Sciences, College of Health Science, University of Uyo, P.M.B. 1017, Uyo, Nigeria

    Itemobong S. Ekaidem

  2. Department of Chemical Pathology, College of Medical Sciences, University of Calabar, Calabar, Nigeria

    Debayo M. Bolarin, Alphonsus E. Udoh & Christopher E. J. Udiong

  3. Department of Obstetrics and Gynaecology, College of Medical Sciences, University of Calabar, Calabar, Nigeria

    Saturday J. Etuk

Authors
  1. Itemobong S. Ekaidem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debayo M. Bolarin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alphonsus E. Udoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saturday J. Etuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christopher E. J. Udiong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Itemobong S. Ekaidem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ekaidem, I.S., Bolarin, D.M., Udoh, A.E. et al. Plasma Fibronectin Concentration in Obese/Overweight Pregnant Women: A Possible Risk Factor for Preeclampsia. Ind J Clin Biochem 26, 187–192 (2011). https://doi.org/10.1007/s12291-011-0127-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-011-0127-1

Keywords

Search

Navigation